Features of biliary tract diseases in ketamine abusers: a systematic review of case reports.
Alireza Teymouri, Hadis Nasoori, Maryamsadat Fakheri, Aref Nasiri
Journal of Medical Case Reports March 3, 2024 DOI: 10.1186/s13256-024-04421-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Case report Peer reviewed |
|---|---|
| Sample size | 17 |
| Population | Adult patients with documented ketamine abuse and cholangiopathy or biliary tract disease |
| Topics | Addiction Ketamine Esketamine |
| Keywords | Biliary tract disease Substance abuse Ketamine abuse Biliary disease Drug-induced cholangiopathy Young adult health |
| Citations | 20 |
| Key findings | Ketamine-induced cholangiopathy typically presents in young men with abdominal pain, abnormal liver function, and bile duct dilation, and most patients improve with supportive care. |
Abstract
Anesthesiologists prefer ketamine for certain surgeries due to its effectiveness as a non-competitive inhibitor of the N-methyl-D-aspartate receptor in the brain. Recently, this agent has also shown promise as an antidepressant. However, ketamine can cause hallucinogenic effects and is sometimes abused as an illicit drug. Ketamine abuse has been associated with liver and bile duct complications. This systematic study aims to better understand cholangiopathy in ketamine abusers by reviewing case reports. In this systematic review, a comprehensive literature search was conducted with the terms "biliary tract diseases" and "ketamine". Case reports and case series of adult patients with documented ketamine abuse and reported cholangiopathy or biliary tract disease were included. We extracted the data of relevant information and the results were reported through narrative synthesis and descriptive statistics. A total of 48 studies were initially identified, and 11 studies were finally included in the review. The mean age of the patients was 25.88 years. Of the 17 patients, 64.7% were men. Symptoms often included abdominal pain, nausea, and vomiting. Most patients were discharged with improved symptoms and liver function. Common bile duct dilation and other findings were observed in imaging results and other diagnostic studies. This review highlights the diverse presentations and diagnostic modalities used in ketamine-induced cholangiography. These patients tend to be young men with deranged liver function tests and abdominal pain, which should be taken into consideration. These patients often require a multidisciplinary approach in their management.
Comparable studies
Other systematic reviews and meta-analyses on ketamine for addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Ketamine use: a review Ketamine users | 2011 | Systematic review | |
| Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review | 2021 | Systematic review | |
| Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature | 2021 | Systematic review | |
| Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions. People with harmful alcohol use, alcohol craving, or alcohol withdrawal states,... | 2022 | Systematic review | n = 634 |
| Ketamine Treatment for Alcohol Use Disorder: A Systematic Review. Adult patients with alcohol use disorder, heavy drinkers, or those undergoing alcohol... | 2023 | Systematic review | n = 854 |
Citations in the library
Cited by 7
- Ketamine-Induced Uropathy in a High-Prevalence Region: Knowledge, Diagnostic Practices, and Treatment Patterns Among Primary and Secondary Care Providers. Cureus June 1, 2025
- Beyond the High: A Narrative Review of the Chronic Complications of Recreational Ketamine Use. British journal of hospital medicine (London, England : 2005) May 18, 2026
- Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic review. General Hospital Psychiatry 2026
- Chronic Ketamine Toxicity Involving both Urinary and Hepatobiliary Systems. Journal of the Belgian Society of Radiology 2026
- Ketamine-Induced Cholangiopathy With Concomitant Hemorrhagic Cystitis: An Emerging and Underrecognized Cause of Cholestasis. Cureus December 1, 2025
and 2 more in the library
Cites 5
- The use of ketamine as an antidepressant: a systematic review and meta‐analysis Human Psychopharmacology: Clinical and Experimental April 7, 2015
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? The Journal of Clinical Psychiatry July 20, 2017
- The abuse liability of ketamine: A scoping review of preclinical and clinical studies. Journal of Psychiatric Research May 1, 2022
- Ketamine and phencyclidine: the good, the bad and the unexpected. British Journal of Pharmacology September 2015
- Cystitis due to the use of ketamine as a recreational drug: a case report. Journal of Medical Case Reports June 26, 2008